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Copyright © 2011 JCBN 2011 This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unre- stricted use, distribution, and reproduction in any medium, pro- vided the original work is properly cited. Low dose acetylsalicylic acid has been widely used. We evaluated
small bowel and gastric injuries during acetylsalicylic acid admin 
istration using video capsule endoscopy and gastroduodenal
endoscopy. We also investigated blood flow using contrast 
enhanced ultrasonography. Six healthy volunteers were enrolled
in this preliminary study. The subjects were administered 100 mg
of enteric coated aspirin daily for 14 days. Video capsule endoscopy
and gastroduodenal endoscopy were simultaneously performed
before administration and on days 1, 3, 7 and 14. Contrast 
enhanced ultrasonography was performed before administration
and on day 2, and 8. Video capsule endoscopy after administra 
tion of low dose acetylsalicylic acid revealed small bowel mucosal
damages of petechiae and erythema in all cases, and denuded
area in one case. The total number of lesions in the small bowel
increased according to duration of low dose acetylsalicylic acid
administration. However, the total number of lesions in the
stomach peaked on day 3. Contrast enhanced ultrasonography
showed that the time intensity curve peak value and Areas under
the curves after acetylsalicylic acid administration were reduced.
We observed not only gastric mucosal injuries but also small
intestinal injuries with short term low dose acetylsalicylic acid
administration. Acetylsalicylic acid administration also caused a
decrease in small intestinal blood flow. Contrast enhanced ultra 
sonography is useful for evaluation blood flow in the small bowel
mucosa.
Key Words: small intestine, capsule endoscopy, low dose aspirin, 
contrast enhanced ultrasonography, healthy subject
Introduction It is well known that nonsteroidal antiinflammatory drug
(NSAIDs) induce upper gastrointestinal (GI) complications,
such as ulcer, bleeding and perforation. Recently, low-dose
acetylsalicyclic acid (ASA) has been used for secondary pre-
vention of cardiovascular events.(1–3) Sakamoto et al.(4) reported
that conventional use of NSAIDs induced upper-GI complications
(odds ratio: 6.1, 95% CI: 2.7–13.4). ASA also induced GI compli-
cations 5.5 fold (odds ratio: 5.5, 95% CI: 2.5–11.9) as well con-
ventional use of NSAIDs in the Japanese population. Thus, it is
becoming clear that ASA,(5–6) as well as NSAIDs caused upper GI
complications. The ACCF/ACG/AHA expert consensus in 2008
reported that the use of low-dose ASA (75 to 325 mg per day) was
associated with a 2- to 4- fold increased risk of upper GI compli-
cations and that PPIs should be used for gastroprotection strategies
in patients at high risk for GI bleeding.(7) However, in some cases,
sites of obscure GI bleeding (OGIB) were not detected despite
examination by colonoscopy and upper endoscopy examination.(8)
Lanas et al.(9) carried out a study to determine the time trends of
hospitalizations resulting from GI complications originating both
from the upper and lower GI tract in the Spanish general popula-
tion and to determine the risk factors, severity, and clinical impact
of these GI events. They showed that the incidence of upper GI
complications decreased from 87/100,000 in 1996 to 47/10,000 in
2005, whereas the incidence of lower GI complications increased
from 20/100,000 to 33/100,000. In Japan, “The Japanese Study
Group for Double-Balloon Endoscopy” (JSG-DBE) established a
database in subjects indicated for double-balloon endoscopy.
Frequency of GI bleeding in NSAIDs users was significantly
higher than that in non-NSAIDs users (79% vs 44%). Mucosal
breaks were detected by double-balloon endoscopy in 51% of the
NSAIDs users and in 5% of non-NSAID users.(10,11) These results
showed that we should observe GI complications for patients with
NSAIDs, as well as the relief of pain.
In 2001, the Food and Drug Administration approved a wireless
VCE device (Given Diagnostic Imaging System, Given Imaging
Ltd, Norcross, GA), which has since altered the management of
patients with OGIB through its ability to directly image the small
bowel mucosa.(12,13) Since the development of VCE, the clinical
significance and frequency of adverse events with non-selective
NSAIDs in the lower GI tract have been increasingly reported.
Using capsule endoscopy, Graham et al. reported that more small-
intestinal injuries were observed in 71% of NSAID users than in
10% of non-NSAID users.(14) In the same year, several studies
using capsule endoscopy showed that the incidences of NSAID-
induced small-intestinal injuries in healthy subjects were 55%
to 68%.(15,16) On the other hand, investigation about the small
intestinal injury development of symptoms by low-dose ASA is
also advanced. Endo et al. reported that short-term low-dose ASA
administration in healthy volunteers induced mild mucosal
damage but not mucosal breaks.(17) Smesuol et al.(18) reported that
short-term low-dose ASA administration induced small intestinal
injuries with more severity. Thus, whether low-dose ASA induces
small intestinal injury is still controversial. However, taking of
low-dose ASA may be suggested a possibility to have played a
certain role for small intestinal injury.
We evaluated small bowel and gastric injuries during low-dose
ASA administration using VCE and gastroduodenal endoscopy.
We also investigated blood flow in the small intestine using
contrast-enhanced ultrasonography (low mechanical harmonic
index imaging).
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Materials and Methods
A preliminary trial was performed in six healthy volun 
teers. The study protocol was approved by the Ethics Committees
of Hokkaido University Hospital, and written informed consent
was obtained from all subjects.
Inclusion and exclusion criteria. Inclusion criteria were
healthy subjects without gastric conditions such as erosions,
erythema, bleeding, and ulcer on endoscopy. Subjects who
habitually smoked or drank alcohol and subjects who took any
medicines were excluded.
Study design. This study was an open-label and single-arm
trial. VCE and gastroduodenal endoscopy were performed before
administration and on days 1, 3, 7 and 14 (five times in total).
All eligible subjects were administered aspirin at 100 mg once
daily for a period of two weeks (Fig. 1). Subjects that developed
any symptoms warranting discontinuation of treatment or with
incomplete post-treatment VCEs were excluded from final analysis.
A time-intensity curve (TIC) for blood flow in the small intestine
was plotted from recorded ultrasonographic images with Image
Lab software. Areas under the curves (AUCs) and TIC peak value
were calculated from TIC.
Gastroduodenal endoscopy. Gastroduodenal endoscopy was
performed using a GIF-XQ240 (Olympus, Tokyo, Japan) after 3
min local anesthesia of the pharynx with lidocaine. Endoscopic
findings were assessed by one endoscopist.
Capsule endoscopy. A Given video capsule system
(PillcamTM, Given Imaging Ltd., Yoqneam, Israel) was used for
this study. Subjects fasted 12 h before swallowing the capsule. A
light snack was permitted 4 h after capsule ingestion. Data were
collected for up to 8 h after capsule ingestion. Repeat VCE of the
small intestine due to system failure (image loss or low signal)
was permitted only if capsule excretion was confirmed. All video
images were analyzed by two skilled reviewers who were blinded
for subjects and timing to be examined VCEs. All images were
saved for final comprehensive analysis at the completion of all
post-treatment VCEs.
Contrast enhanced ultrasonography (CE US). The longi-
tudinal view of the small intestine was imaged in the left upper
abdomen. Baseline US and contrast-enhanced US were performed
with a 7.5 MHz center frequency linear transducer using an ultra-
sound unit SSA-790A (AplioXG(TM), Toshiba Medical Systems
Corp., Otawara, Japan) The imaging mode was pulse subtraction.
Prior to CEUS, 20 mg of scopolaminebutylbromide was injected
intravenously to suppress peristalsis. Perflubutane microbubbles
(Sonazoid, Daiichi Sankyo, Tokyo, Japan), a lyophilized prepara-
tion reconstituted for injection, were injected intravenously at a
concentration of 0.05 ml/kg. Ten seconds after contrast medium
injection, enhanced signals from blood flow in the small intestinal
wall were captured until 45 s on cine clipsequipped with ultra-
sound unit. Regions of interests of fixed sizes were placed in the
mucosal area of the small intestine at three regions. A TIC of
blood flow enhancement signal in the small intestine was plotted
from recorded ultrasonographic images using ImageLab, which
was developed by C++ software dedicated to US images obtained
by AplioXG.(19) AUC and TIC peak value (maximum intensity)
were calculated from the TIC. These values were used to estimate
small intestinal blood flow inside the mucosal layer (Fig. 2).
Review of VCE. Investigators who were to evaluate the
results of video VCE of the small intestine were required to attend
a standardized training session on use of the Given Diagnostic
System. These two investigators (U.N. and S.F.) were instructed
to mark any significant lesions with a blinded condition and to
evaluate lesions according to the criteria for determination of
endpoints. It is difficult or impossible to evaluate erosion from an
ulcer with capsule endoscopy. If different results between the two
investigators existed, the two investigators achieved a consensus.
Evaluation of gastric injury. In this study, mucosal injuries
of the upper GI were shown as sum total number of erythema,
petechiae, erosion, and ulcer.
Evaluation of small intestinal injury. In this study, mucosal
injury of the small intestine was defined as lesions with slough
surrounded by erythema. Denuded area was defined as reddened
area without villi. Total small intestinal mucosal injury was
defined as sum total number of petechiae, erythema, and denuded
area (Fig. 3). Small intestinal blood flow was expressed in AUC
and maximum intensity.
Fig. 1. Study design.
Fig. 2. Time intensity curve (TIC) for blood flow in the small intestine
using contrast enhanced ultrasonography. Typical image of TIC was
shown to upper. These intensity curves by measured ultra sonography
indicated for blood flow in the small intestine. The vertical arrow
was defined as the TIC peak value and area under curve (AUC) was
calculated. J. Clin. Biochem. Nutr. | May 2011 | vol. 48 | no. 3 | 247
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Evaluation of adverse events. Clinical laboratory and
physical examinations were performed to assess safety before
and after study, and for observation of adverse events.
Statistical analysis. Comparisons of temporal injury, AUC,
and maximum intensity were carried out by Wilcoxon’s test with
correspondence. It was analyzed for the correlation coefficient
about the relation between AUC and small intestinal injury. AUC
and max intensity of 6 subjects were expressed as mean, standard
deviation, absolute difference, and 95% confidential interval. All
statistical analyses were performed using SAS® version 8.2 (SAS
Institute, Cary, NC). Data were expressed as mean values ± SD.
p values <0.05 were considered significant.
Results
Mucosal injuries on post 1st, 3rd, 7th and 14th days detected by
capsule and gastroduodenal endoscopy. The time-course changes
of gastric mucosal injuries are shown in Table 1. The total
numbers of gastric mucosal injuries were 0.8 ± 1.6 on the 1st day,
5.5 ± 6.9 on the 3rd day, 1.0 ± 0.9 on the 7th day and 3.3 ± 4.4 on
the 14th day. These numbers were not significantly different from
the basal numbers of gastric injuries. The total numbers of small
intestinal injuries were 13.5 ± 19.7 on the 1st day, 13.5 ± 20.5 on
the 3rd day, 13.5 ± 12.0 on the 7th day and 18.0 ± 18.5 on the 14th
day. These numbers were also not significantly different from the
basal numbers of intestinal injuries.
Time-intensity curve (TIC) for blood flow in the small intestine.
AUC of the TIC decreased from 223.6 ± 106.6 (basal level) to
166.6 ± 94.8 on the 2nd day (difference: −56.9, 95% CI: −113.5–
−0.5, p = 0.0484) and 125.0 ± 85.8 on the 8th day (difference:
−98.5, 95% CI: −199.5– −2.4,  p = 0.0539) (Table 2). Max
intensities decreased from 26.3 ± 4.2 (basal level) to 21.9 ± 8.4 on
the 2nd day (difference: −4.4, 95% CI: −12.1– −3.3, p = 0.2044)
and to 18.8 ± 7.3 on the 8th day (difference: −7.5, 95% CI: −16.5–
−1.4, p = 0.0847) (Table 2).
Relationships among small intestinal injury, gastroduodenal
injury, and small intestinal blood flow. A significant correlation
between total numbers of gastric and small intestinal injuries was
found on the 3rd day (y = −1.58 + 2.74x,  p = 0.0325) (Fig. 4).
There were no significant correlations on the other days.
Adverse events. Clinical symptoms were not observed
throughout the study.
Discussion
Although small intestinal injury caused by NSAID use is an
important clinical research theme,(20) it is a still more important for
ASA-use in order to lead to fatal. And it may be slight mucosal
injury; it is still unknown whether low-dose ASA-induced slight
mucosal injury is correlated with serious clinical symptoms.
In this preliminary study, there were some healthy subjects in
whom injuries of both the gastric and small intestinal mucosa were
induced in the very early phase (at 1 or 3 days). The degree of
injuries was slight, such as petechiae, and no erosion or ulcer was
observed. The point which should be mentioned especially was to
be stratified in the category between easy and hard to cause injury
(Table 1). In addition, each subject was following a different
course. In case 1, there were no gastric and small intestinal injuries
throughout the study period, whereas in case 2, gastric mucosal
injuries were observed strongly on the 3rd day and disappeared
after that. Moreover small intestinal injuries were observed
strongly on the 1st and 3rd days and disappeared after that in
case 2. In case 3, although severe gastric mucosal injuries were
observed, there was little small intestinal injury. In case 4, there
was no injury to the stomach, but injury to the small intestine was
observed. In case 5, there were injuries to the gastric mucosa
and small intestine, and small intestinal injury showed periodic
recurrence. In case 6, continuous taking low-dose ASA was
increasing injury to gastric and small intestine, pile up medication
days. In cases 2, 5 and 6, similar changing was observed in both
the occurrence of small intestinal injury and decrease in blood
flow.
Smecuol  et al.(18) reported serious small intestinal injuries,
including erosion, ulcer, and bleeding taking low-dose ASA in 10
healthy subjects. However, no serious small intestinal injury was
detected in the 6 healthy subjects in the present study. In other
studies we examined the number of the redness lesions by dividing
it into a group having mucosal break and the group who do not
have. It was significantly different. Therefore, it is thought that the
number of the redness lesions suggests the degree of the injury.
And we should know that not all individuals equally responded to
low-dose ASA. This has been called “ASA resistance”. Hovens
et al.(21) found great differences in the prevalence of ASA resis-
tance in a meta-analysis of patients taking ASA for secondary
prevention and calculated mean prevalence of 22.4%, 26.0% and
27.3% in patients with CAD, stroke and miscellaneous diseases.
Fig. 3. Mucosal injury of the small intestine during capsule endoscopy. a: Petechiae b: Denuded area was defined as reddened area without villi.doi: 10.3164/jcbn.10 112
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However, the mechanisms of ASA resistance are still not clear.
Moreover, in case 2, mucosal injuries were restored in both
upper and lower. Kawai et al.(22) reported that low-dose ASA-
induced GI complications were occurred at 3 days and were
reduced at 7 days after the start of ASA administration. This
phenomenon was concluded as adaptation. Adaptation may be
also observed in our study. Increasing permeation of the small
intestine is known to be one of mechanisms causing injury. AUC
of the TIC and maximum intensity in the small intestine were
significantly decreased on day 2 (from 223.6 ± 106.6 to 166.6 ±
94.8, difference; −56.9, 95% CI; −113.5– −0.5,  p = 0.0484)
(Table 2).
Ultrasonography is less-invasive, reputably performed and
increase economic efficiency no incidence of adverse events was
Table 1. The effect of low dose aspirin induced upper and lower injuries
Number of injuries were calculated as total number of small intestinal and gastric petechiae, erythema, and denuded.
Subject number pre 1 3 7 14 (days)
Upper GI injuries 1 1 1 1 1 1
2 00 1 810
30 4 7 2 1 2
4 00002
5 40722
6 00003
mean ± SD 0.8 ± 1.6 0.8 ± 1.6 5.5 ± 6.9 1.0 ± 0.9 3.3 ± 4.4
Lower GI injuries
petechiae 1 0 3 1 2 0
2 0 56 58 14 21
3 02026
4 1 12 0 5 9
51 449 2 46
6 0 31 33 44 9
erythema 1 0 0 0 0 0
2 01003
3 00001
4 00003
5 10001
6 00006
denuded 1 0 0 0 0 0
2 00003
3 00000
4 00000
5 00000
6 00000
Total number of injuries 
(mean ± SD)
2.7 ± 5.5 13.5 ± 19.7 13.5 ± 20.5 13.5 ± 12.0 18.0 ± 18.5
Table 2. Time intensity curve (TIC) for blood flow in the small intestine
Subject number pre 2 8 (days)
AUC 1 139.4 37.4 24.3
2 286.7 222 201.2
3 94 86.4 79.8
4 295.4 286 254.4
5 160 139.7 107
6 364.9 228 83.3
mean ± SD 223.6 ± 106.6 166.6 ± 94.8 125.0 ± 85.8
Differences –56.9 –98.5
95% CI –113.5– –0.5 –199.5–2.4
p = value 0.0484 0.0539
Max intensity 1 21.6 6.5 10.4
2 24.5 31.4 31.3
3 22 20.6 19.4
4 30.2 26.2 20.8
5 31.4 22.4 13.2
6 28.3 24.5 17.7
mean ± SD 26.3 ± 4.2 21.9 ± 8.4 18.8 ± 7.3
Differences –4.4 –7.5
95% CI –12.1–3.3 –16.5–1.4
p = value 0.2044 0.0847 J. Clin. Biochem. Nutr. | May 2011 | vol. 48 | no. 3 | 249
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self limited. Laser Doppler flowmetry is considered to be the gold
standard, but it requires insertion of an endoscope and is difficult
to use routinely. We therefore used contrast-enhanced ultrasono-
graphy. This method is useful for evaluating blood flow in the
mucosal layer of the small intestine. We started this study after
having proved reproducibility of the CE-US evaluation.
However, there are limitations to our study; for example, the
position of ultrasound probe placement could not be made exactly
the same throughout the entire study in one subject. The problem
with this method is that correction for ultrasound beam attenuation
is needed. However, we tried as much as possible to have the
same ultrasound plane according to surroundings structures such
as vessels and the layer and thickness of the abdominal wall, so
that effects of differences could be kept to a minimum. Also, only
one skilled sonographer (M. N) performed ultrasound throughout
the study.
There are also problems with penetration in obesity and with
intestinal air impairing image quality.(23) The period of each study
was two weeks, so that body weight of a subject was not signifi-
cantly different. We performed ultrasound study in the early
morning to avoid peristalsis, and subjects in a fasted state. So
there would be almost no influence of a meal and physics.
Another limitation was the inaccuracy of placing the regions of
interest (ROI) in the analysis of TIC. The ROIs were placed in a
plane of the small intestine to avoid perforator and we tried to put
them in the same positions as those in the previous study as much
as possible. Therefore, we believe that little mismatching actually
occurred.
In conclusion, we observed not only gastric mucosal injuries but
also small intestinal injuries in subjects receiving low-dose ASA.
Small intestinal blood flow was also decreased ASA administra-
tion. It was shown the possibility as diagnostic modality for ultra-
sonography. It should be needed to research for the preventive
effect of tentative drug.
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Abbreviation
ACCF/ACG/AHA
American College of Cardiology Foundation/ 
American College of Gastroenterology/ 
American Heart Association
ASA acetylsalicyclic acid
AUCs Areas under the curves
CE-US Contrast-enhanced ultrasonography
GI gastrointestinal
JSG-DBE Japanese Study Group for Double-Balloon Endoscopy
NSAIDs nonsteroidal antiinflammatory drug
OGIB obscure GI bleeding
PPIs proton pump inhibitors
ROI regions of interest
TIC time-intensity curve
VCE video capsule endoscopy
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